CLOUGH CAPITAL PARTNERS L P - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 320 filers reported holding GW PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
CLOUGH CAPITAL PARTNERS L P ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q4 2020$10,558,000
-43.1%
91,486
-52.0%
0.75%
-43.8%
Q3 2020$18,566,000
+50.2%
190,716
+89.3%
1.34%
+10.3%
Q2 2020$12,364,000
+36.6%
100,746
-2.5%
1.21%
+34.4%
Q1 2020$9,050,000
-33.4%
103,346
-20.5%
0.90%
-22.5%
Q4 2019$13,597,000
+115.3%
130,036
+136.9%
1.16%
+122.4%
Q3 2019$6,314,000
-47.8%
54,887
-21.7%
0.52%
-55.9%
Q2 2019$12,086,000
+53.8%
70,107
+50.4%
1.18%
+72.5%
Q1 2019$7,857,000
+18.3%
46,607
-31.7%
0.69%
-12.0%
Q4 2018$6,644,000
-3.8%
68,217
+70.6%
0.78%
+19.8%
Q3 2018$6,908,000
-3.7%
39,991
-22.2%
0.65%
+1.9%
Q2 2018$7,171,000
-18.1%
51,391
-33.9%
0.64%
-23.5%
Q1 2018$8,753,000
-9.0%
77,691
+6.6%
0.84%
+4.4%
Q4 2017$9,620,000
+10.3%
72,871
-15.2%
0.80%
+37.1%
Q3 2017$8,725,000
+81.4%
85,971
+79.2%
0.58%
+75.1%
Q2 2017$4,809,000
-59.5%
47,971
-51.1%
0.33%
-55.7%
Q1 2017$11,876,000
+124.7%
98,200
+107.6%
0.75%
+115.4%
Q4 2016$5,286,000
+11.6%
47,300
+32.5%
0.35%
+41.7%
Q3 2016$4,738,000
+1297.6%
35,700
+864.9%
0.25%
+1272.2%
Q2 2016$339,000
-97.8%
3,700
-98.3%
0.02%
-97.5%
Q4 2015$15,296,000
-13.3%
220,276
+14.1%
0.72%
-6.3%
Q3 2015$17,637,000
-30.3%
193,027
-6.3%
0.76%
-21.1%
Q2 2015$25,315,000
+19.6%
206,080
-11.2%
0.97%
+38.1%
Q1 2015$21,160,000
+269.5%
232,200
+174.5%
0.70%
+241.5%
Q4 2014$5,726,000
-63.2%
84,600
-56.1%
0.20%
-64.9%
Q3 2014$15,572,000192,6000.58%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q4 2019
NameSharesValueWeighting ↓
VHCP Management, LLC 311,853$25,213,00011.33%
Iguana Healthcare Management, LLC 50,000$4,043,0002.16%
Ghost Tree Capital, LLC 35,000$2,830,0001.54%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 354,278$28,643,0001.06%
Cupps Capital Management, LLC 100,213$8,102,0000.75%
CLOUGH CAPITAL PARTNERS L P 192,600$15,572,0000.58%
FARALLON CAPITAL MANAGEMENT LLC 244,000$19,727,0000.32%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 105,200$8,505,0000.31%
Eventide Asset Management 25,000$2,021,0000.28%
PRUDENTIAL PLC 836,124$67,601,0000.28%
View complete list of GW PHARMACEUTICALS PLC shareholders